Page last updated: 2024-08-26

2,2,5,7,8-pentamethyl-1-hydroxychroman and Hypoxia-Ischemia, Brain

2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Hypoxia-Ischemia, Brain in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, YC; Chou, DS; Hsiao, G; Lee, JJ; Lin, JH; Lin, KH; Shen, MY; Sheu, JR1

Other Studies

1 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Hypoxia-Ischemia, Brain

ArticleYear
Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions.
    Biochemical pharmacology, 2007, Mar-01, Volume: 73, Issue:5

    Topics: alpha-Tocopherol; Animals; Antioxidants; Caspase 3; Chromans; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Male; Molecular Structure; Neuroprotective Agents; Neutrophil Activation; Neutrophils; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine

2007